Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies
Jacqueline van Paassen, Lecturer at Department Pharmaceutical Sciences at Universiteit Utrecht, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Journal of Clinical Pharmacy, adding;
”Our new research is online!
We conducted a mixed-methods study in the International Journal of Clinical Pharmacy, revealing that 92.8 percent of DOAC prescriptions in community pharmacies lacked clinical data, such as treatment indication, renal function, or body weigh, needed to assess their appropriateness.
Using their clinical reasoning skills, community pharmacists requested missing data for over half of these prescriptions, primarily to evaluate dosing.
Motivated by a commitment to optimal patient care, their efforts led to adjustments in 5 percent of cases.
This research highlights the importance of pharmacists verifying DOAC prescriptions to ensure optimal patient care. Clinical data sharing could be optimised by streamlined interprofessional collaboration.”
Title: Access to clinical data for direct oral anticoagulant prescriptions in community pharmacy and implications for medication optimisation: a mixed‑methods study
Authors: Jacqueline G. van Paassen, Vera H. M. Deneer, Thomas G. H. Kempen, Marcel L. Bouvy

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 31, 2026, 14:03Adil Aftab: Anticoagulation in CKD – Key Updates from the 2026 ESC Guidelines
-
Aug 31, 2026, 14:01Isa Oboirien: Why Might Factor XI Inhibition Work Differently in Stroke and ACS?
-
Aug 31, 2026, 13:55Mike Morrissey: Advancing Europe’s Cardiovascular Health Agenda at ESC Congress 2026
-
Aug 31, 2026, 13:44Penilla Gunther: Patient Voices Take Center Stage in Cardiovascular Prevention at ESC Congress 2026
-
Aug 31, 2026, 13:42Mohamed Saleh Gomaa: Master the Latest in PE Management
-
Aug 31, 2026, 13:38Lyn Kleinbach-Reilly: A New Standard for Coagulation Testing in Neonatal Care
-
Aug 31, 2026, 13:36Rafael Gomes: Can Prasugrel Replace Ticagrelor in ACS Treatment?
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients